Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00129324 · ClinicalTrials.gov registry record · NA
HOME Study (Health Outcomes and Measures of the Environment Study)
A NA study, sponsored by National Institute of Environmental Health Sciences (NIEHS).
- Completed
- Registry status
- NA
- Development phase
- 468
- Enrollment target
NCT00129324: Completed NA study, sponsored by National Institute of Environmental Health Sciences (NIEHS).
NCT00129324 is a NA study that has completed, run by National Institute of Environmental Health Sciences (NIEHS). The registered enrollment target is 468 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (67% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00129324, a NA study, has completed, sponsored by National Institute of Environmental Health Sciences (NIEHS).
- COMPLETED
- Registry status
- NA
- Development phase
- 468 participants
- Enrollment target
Study Summary
The goal of the HOME Study is to quantify the impact of low-level fetal and early childhood exposures to environmental toxicants including lead, mercury, and other metals, pesticides, polychlorinated biphenyls (PCBs), persistent organic pollutants (PBDEs/PFCs), phthalates, phenols, environmental tobacco smoke, and alcohol on child development, neurobehavior, health, and growth. The HOME Study will also evaluate meconium as a biomarker for fetal exposure and test the effectiveness of home repairs to control lead hazards and injuries in early childhood.
Primary Outcome
Testing the efficacy of lead reduction controls in the homes of participants. Examining the effects of low level blood lead concentration on child development and neurobehavior. Measures of blood lead concentration were taken from mothers prenatally at approximately 16 and 26 weeks gestation, from cord blood at birth, and annually from participating children from 1 - 10 years of age.
Interventions
- PROCEDURE Lead Hazard Control Intervention
- PROCEDURE Injury Hazard Control Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 468 participants |
| Start Date | 2003-03 |
| Est. Completion | 2018-08 |
| Phase | NA |
What the finished NCT00129324 record still lists
NCT00129324 is an interventional study that assigns participants to a tested intervention. The registered 468 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (67% lower).
The record links to 0 conditions, and to 2 interventions - of which Lead Hazard Control Intervention is the first listed.
NCT00129324 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00129324 about?
NCT00129324 is a clinical study titled "HOME Study (Health Outcomes and Measures of the Environment Study)". The goal of the HOME Study is to quantify the impact of low-level fetal and early childhood exposures to environmental toxicants including lead, mercury, and other metals, pesticides, polychlorinated biphenyls (PCBs), persistent organic pollutants (PBDEs/PFCs), phthalates, phenols, environmental tob...
What is the current status of trial NCT00129324?
This trial is currently completed. It is a NA study. The enrollment target is 468 participants. The study started on 2003-03. Estimated completion is 2018-08.
What interventions are being tested in trial NCT00129324?
The interventions under investigation include: Lead Hazard Control Intervention (PROCEDURE), Injury Hazard Control Intervention (PROCEDURE).
Who is sponsoring clinical trial NCT00129324?
This trial is sponsored by National Institute of Environmental Health Sciences (NIEHS), which has 145 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00129324's enrollment target sits among peer trials
468 222nd of 2000 higher than 1,779 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03124303 · 468 participants
Interventions for Postoperative Delirium: Biomarker-3
- NCT03901924 · 468 participants · NA
Volume Support/Assist Control Mode Ventilation and Diaphragmatic Atrophy
- NCT04482309 · 468 participants · Phase 2
A Phase 2 Study of T-DXd in Patients With Selected HER2 Expressing Tumors
- NCT05357170 · 468 participants
Microbiome Dysfunction in Surgical Intensive Care Unit Survivors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia